Skip to main content

Animations

MJFF Publications

3831 - 3840 of 6456 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2025
  • 2020
  • 2025
  • 2021
  • 2019
  • 2022
  • 2021
  • 2019
  • Summary Details
    OPEN
    Title: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20180484
    Citation Count: 104
  • Summary Details
    OPEN
    Title: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040
    Citation Count: 678
  • Summary Details
    OPEN
    Title: External delay and dispersion correction of automatically sampled arterial blood with dual flow rates
    Journal Name: Biomedical Physics & Engineering Express
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/2057-1976/adae13
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Is Levodopa Response a Valid Indicator of Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28406
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Personalised regional modelling predicts tau progression in the human brain
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003241
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01283-7
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Identification of N-linked glycans as specific mediators of neuronal uptake of acetylated α-Synuclein
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3000318
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00388-7
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-24567-x
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic Stimulation
    Journal Name: Research
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.34133/2019/7109535
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.